Back to Search
ERIC DRISCOLL, D.O.
D.O.
Internal Medicine Physician
NPI: 1730192691IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
25MB07015200(NJ)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1996
Research & Publications (18)
Disodium disuccinate astaxanthin prevents carotid artery rethrombosis and ex vivo platelet activation.
PMID 18477858·Pharmacology·2008
7-preclinical
Preclinical evaluation of S18886 in an experimental model of coronary arterial thrombosis.
PMID 17110806·J Cardiovasc Pharmacol·2006
7-preclinical
Effect of sodium/hydrogen exchange inhibition on myocardial infarct size after coronary artery thrombosis and thrombolysis.
PMID 16899991·Pharmacology·2006
7-preclinical
Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model.
PMID 16580537·J Am Coll Cardiol·2006
7-preclinical
The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study).
PMID 16160608·J Cardiovasc Pharmacol·2005
4-observational
Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2.
PMID 15681653·Biophys J·2005
7-preclinical
Perioperative surgery in the twenty-first century--two case studies.
PMID 15526705·AORN J·2004
8-other
Prevention of carotid artery thrombosis after oral administration of the glycoprotein IIb/IIIa antagonist CRL42796.
PMID 12827029·J Cardiovasc Pharmacol·2003
7-preclinical
Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator.
PMID 12734394·J Pharmacol Exp Ther·2003
7-preclinical
Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.
PMID 12110617·Br J Pharmacol·2002
7-preclinical
Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.
PMID 12023550·J Pharmacol Exp Ther·2002
7-preclinical
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries.
PMID 11816721·Thromb Haemost·2001
4-observational
Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
PMID 11502709·Circulation·2001
7-preclinical
Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
PMID 11264243·Br J Pharmacol·2001
7-preclinical
Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
PMID 11046080·J Pharmacol Exp Ther·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 707 WHITE HORSE PIKE STE C1
ABSECON, NJ 08201 - Phone
- (609) 813-2200
Quick Facts
- NPI
- 1730192691
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 18
Are you this provider?
Claim Your Profile